Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting.


BACKGROUND Although patients undergoing coronary stenting routinely receive dual antiplatelet treatment to reduce the risk of stent thrombosis, this undesired event still occurs. A suboptimal response to clopidogrel treatment (low responders) has been suggested to contribute to stent thrombosis. In the present study, platelet function profiles were assessed… (More)